Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
Cirrus Therapeutics has raised $11.0M in total funding. The most recent round was Seed. The last funding was announced in August 2025.
Cirrus Therapeutics's investors include Polaris Partners, ZAKA VC, ClavystBio, Seeds Capital.
Cirrus Therapeutics is headquartered in Cambridge, United States.
Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
Cirrus Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cirrus Therapeutics — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/cirrus-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Cirrus Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cirrus-therapeutics
{{cite web |title=Cirrus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cirrus-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated